LaNova Medicines

Healthcare & Life Sciences

Recent Finacing

Series C

Recent Raise

$42M

LaNova Medicines is a biotech company specializing in antibody-drug conjugates (ADCs) and immuno-oncology, focusing on developing treatments like their anti-PD-1/VEGF bispecific antibody for cancer.

Total Funding

$42M

Headquarters

Shanghai, China

Founded

2019

Website

lanovamedicines.com

Focus Areas

Biotech

ADCs

Immuno-oncology

Clinical development

Bispecific antibody

Phase 1 trial

Investors